For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Researchers at the University of Amsterdam (UvA), Academic Medical Center (AMC-UvA) and Leiden University Medical Center (LUMC) have received an IOP grant worth almost 1 million euros for the IMPACT research project.

Researchers at the University of Amsterdam (UvA), Academic Medical Center (AMC-UvA) and Leiden University Medical Center (LUMC) have received an IOP grant worth almost 1 million euros for the IMPACT research project. They received this amount within the framework of the IOP Photonic Devices 2010 project round organised by the NL Agency, an agency of the Ministry of Economic Affairs, Agriculture and Innovation. This brings the total project budget to 1.5 million euros.

The research groups of Dr. H. Zhang from the UvA’s Van 't Hoff Institute for Molecular Sciences, Dr M. Aalders of the AMC-UvA and Prof. C. Löwik from the LUMC are all participating together in this project focusing on medical nanotechnology. The research should make it easier to find tumors, delimit them well and treat them more precisely.

IMPACT research project

Most tumors are detected at a relatively late stage and are still treated by conventional methods such as surgery or radiotherapy, despite the many disadvantages to these techniques. This is the reason for the search for less invasive, locally applicable techniques with the main result, so far, being the development of photodynamic therapy (PDT). The technique uses a ‘photosensitizer’ which is administered to the patient and which, preferably, accumulates selectively in a patient’s aberrant tissue. After being activated with light, a cascade reaction occurs resulting in the destruction of the cells.

About IOP

IOP stands for innovative research programmes. The government wants to use this scheme to make the world of research more accessible to the business community and improve and intensify the contact between these two worlds. In addition to the knowledge institutes listed above, two commercial companies -O2view and Percuros- are also taking part in this scheme.